VEGFA and cancer: Therefore, uPAR silencing or the block of its interaction with integrins, together with standard treatment against VEGF, could be a possible therapeutic strategy impairing vascular growth and cancer cell invasion at the same time, overcoming resistance to anti-VEGF and anti-protease therapy.